Latest News  

Certolizumab Pegol Receives FDA Approval for Plaque Psoriasis

On the basis of data from multiple clinical trials, the FDA has approved certolizumab pegol for treating moderate to severe plaque psoriasis… [Read More]

Targeted Rheumatoid Arthritis Treatment Does Not Improve Mental Health

NEW YORK (Reuters Health)—Effective pharmacotherapy of rheumatoid arthritis (RA) is not associated with meaningful improvements in mental health, according to a systematic review and meta-analysis…. [Read More]

Lilly’s Lupus Treatment Succeeds in Mid-Stage Trial

(Reuters)—Eli Lilly & Co said its drug to treat autoimmune disease lupus met the main goal of a mid-stage trial, positioning the drugmaker to begin… [Read More]

U.S. Justice Department Says Obamacare Individual Mandate Unconstitutional

WASHINGTON (Reuters)—The U.S. Department of Justice (DOJ) said on Thursday that the part of Obamacare requiring individuals to have health insurance is unconstitutional, an unusual… [Read More]

Hip Bone Deterioration May Differ Significantly Between Men & Women

NEW YORK (Reuters Health)—Various image analysis techniques show sex-specific patterns of bone deterioration at the hip, suggesting that men and women should be assessed differently… [Read More]

Fed Up with Rising Costs, Big U.S. Firms Dig Into Healthcare

SAN JOSE, Calif., (Reuters)—At its Silicon Valley headquarters, network gear maker Cisco Systems Inc. is going to unusual lengths to take control of the relentless… [Read More]

View More Latest News »